Growing Demand For Natural Therapies Will Open Global Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
18 Aug 25
Updated
18 Aug 25
AnalystHighTarget's Fair Value
US$40.00
94.8% undervalued intrinsic discount18 Aug
US$2.07
1Y
-93.3%7D
-4.6%